EP2707015
LIXISENATIDE AS ADD-ON THERAPY TO BASAL INSULIN IN TYPE 2 DIABETES
:
EP einkaleyfi: Þýðing ekki lögð inn:
11.5.2012:
9.11.2016:
12721268.6
:
10.5.2032
:
LIXISENATIDE AS ADD-ON THERAPY TO BASAL INSULIN IN TYPE 2 DIABETES
11.5.2012
9.11.2016
:
Sanofi-Aventis Deutschland GmbH:
Brüningstraße 50, 65929, Frankfurt am Main, DE
:
NIEMÖLLER, Elisabeth:
Frankfurt am Main, DE
:
SILVESTRE, Louise:
Paris, FR
:
BOKA, Gabor:
Paris, FR
:
MIOSSEC, Patrick:
Paris, FR
:
11166111:
13.5.2011:
EP
:
EP2012058749:
11.5.2012
:
A61K 38/26, A61K 38/28, A61K 31/155, A61P 3/10, A61P 3/04